COO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.88

Margin Of Safety %

Put/Call OI Ratio

1.09

EPS Next Q Diff

0.09

EPS Last/This Y

2.74

EPS This/Next Y

0.4

Price

69.66

Target Price

91.67

Analyst Recom

2.1

Performance Q

-15.81

Upside

-36.2%

Beta

1.06

Ticker: COO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	COO	75.82	1.38	14.97	9295
2026-03-10	COO	74.43	1.26	1.72	8879
2026-03-11	COO	73.74	1.17	0.51	8851
2026-03-12	COO	71.53	1.11	53.57	8655
2026-03-17	COO	72.06	1.05	0.52	8533
2026-03-18	COO	71.18	1.05	3.82	8591
2026-03-19	COO	70.7	1.06	0.97	8630
2026-03-20	COO	69.84	1.06	2.75	8645
2026-03-23	COO	70.23	1.19	0.56	4069
2026-03-24	COO	70.49	1.18	0.05	4102
2026-03-25	COO	71.44	1.15	0.05	4160
2026-03-26	COO	71.56	1.14	0.03	4179
2026-03-27	COO	69.8	1.15	0.20	4173
2026-03-30	COO	69.3	1.10	8.89	4300
2026-03-31	COO	71.49	1.10	5.54	4325
2026-04-01	COO	71.4	1.09	0.18	4348
2026-04-02	COO	70.18	1.09	3.00	4350
2026-04-07	COO	69.64	1.09	13.83	4336
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	COO	75.85	14.4	108.3	4.60
2026-03-10	COO	74.43	14.6	102.1	4.61
2026-03-11	COO	73.75	14.6	109.4	4.61
2026-03-12	COO	71.53	14.5	59.0	4.62
2026-03-13	COO	69.92	14.5	63.9	4.62
2026-03-17	COO	72.05	14.5	88.6	4.62
2026-03-18	COO	71.18	14.5	71.1	4.62
2026-03-19	COO	70.70	14.5	74.7	4.62
2026-03-20	COO	69.96	14.5	72.1	4.62
2026-03-23	COO	70.25	14.5	81.9	4.62
2026-03-24	COO	70.50	14.5	82.0	4.62
2026-03-25	COO	71.46	14.4	88.0	4.62
2026-03-26	COO	71.57	14.4	80.3	4.62
2026-03-27	COO	69.77	14.4	62.4	4.62
2026-03-30	COO	69.31	14.4	74.9	4.62
2026-03-31	COO	71.54	14.4	100.5	4.62
2026-04-01	COO	71.42	14.4	78.4	4.62
2026-04-02	COO	70.18	14.4	67.5	4.62
2026-04-06	COO	70.27	14.4	80.1	4.62
2026-04-07	COO	69.66	14.4	73.4	4.62
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	COO	1.39	-1.32	3.54
2026-03-10	COO	1.39	-1.32	3.54
2026-03-11	COO	1.40	-1.32	3.38
2026-03-12	COO	1.40	-1.32	3.38
2026-03-13	COO	1.40	-1.32	3.38
2026-03-17	COO	1.40	-1.35	3.38
2026-03-18	COO	1.40	-1.35	3.38
2026-03-19	COO	1.40	-1.35	3.38
2026-03-20	COO	1.40	-1.35	3.38
2026-03-23	COO	1.40	-1.34	3.38
2026-03-24	COO	1.40	-1.34	3.38
2026-03-25	COO	1.40	-1.34	2.88
2026-03-26	COO	1.40	-1.34	2.88
2026-03-27	COO	1.40	-1.34	2.88
2026-03-30	COO	1.24	-1.34	2.88
2026-03-31	COO	1.24	-1.34	2.88
2026-04-01	COO	1.24	-1.34	2.88
2026-04-02	COO	1.24	-1.34	2.88
2026-04-06	COO	1.24	-0.95	2.88
2026-04-07	COO	1.24	-0.95	2.88
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.1

Avg. EPS Est. Next Quarter

1.19

Insider Transactions

1.24

Institutional Transactions

-0.95

Beta

1.06

Average Sales Estimate Current Quarter

1053

Average Sales Estimate Next Quarter

1119

Fair Value

93.83

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.9

Max Drawdown 5-Year %

-45.4

Target Price

91.67

P/E

34.48

Forward P/E

13.85

PEG

1.42

P/S

3.27

P/B

1.62

P/Free Cash Flow

27.67

EPS

2.02

Average EPS Est. Cur. Y

4.62

EPS Next Y. (Est.)

5.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.67

Relative Volume

1.04

Return on Equity vs Sector %

-22.7

Return on Equity vs Industry %

-4.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.11

EBIT Estimation

73.4

◆ COO Healthcare

$69.66

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

4/15

Valuation

20/20

TP/AR

5/10

Options

2/10

RSI

34.5

Range 1M

6.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

12/30

Estimates

12/20

Inst/Vol

1/15

Options

3/10

EPS Yr

12.1%

EPS NY

8.9%

52W%

26.3%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +46% upside

Quality

11/30

Valuation

22/30

Growth

14/25

Stability

5/10

LT Trend

4/5

Upside

+46%

Quality

MoS

35%

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 15000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO

Latest News

—

Caricamento notizie per COO…

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y